The treatment of people with HIV infection is rapidly progressing, as new data from clinical studies are presented and published. This new information affects key clinical decisions in many areas of HIV patient care. However, it is not always possible for clinicians to keep up with the flood of new information. This dinner meeting series addresses this gap with open-forum structured programs in which national thought leaders will present and discuss important HIV/AIDS treatment challenges. These case-based, interactive meetings will provide patient vignettes to illustrate developing treatment choices and prevention strategies. Participation in the dinner program should enhance understanding of treatment options and help clinicians prepare treatment plans that are best suited to the individual needs of patients.
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.
Upon completion of the program, participants should be able to:
Describe when and which agents to start regarding ARV therapy;
Describe strategies for individualizing the care of HIV/AIDS patients;
Illustrate the use of new or novel ARV therapies and regimens;
Demonstrate ARV sequencing and switching options in various patient scenarios.
Calvin J. Cohen, MD, MS
Research Director,
CRI New England
Clinical Instructor,
Harvard Medical School
Boston, Massachusetts
|
Eric Daar, MD |
Judith Feinberg, MD |
|
Edwin DeJesus, MD |
W. David Hardy, MD |
|
Richard A. Elion, MD |
Trevor Hawkins, MD |
|
Ian Frank, MD |
Andrew Zolopa, MD |
|
Wednesday, November 2, 2011 |
Tuesday, November 29, 2011 |
Wednesday, December 7, 2011 |
|
Thursday, November 3, 2011 |
Tuesday, November 29, 2011 |
Thursday, December 8, 2011 |
|
Wednesday, November 9, 2011 |
Wedensday, November 30, 2011 |
Wednesday, December 14, 2011 |
|
Thursday, November 17, 2011 |
Tuesday, December 6, 2011 |
Wednesday, December 14, 2011 |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Supported by an independent educational grant from Merck & Co., Inc.
 |
 |
